Latest Buy Back Programs News

Fat Prophets Global Contrarian Fund (ASX: FPC) has launched an on-market buy-back of its ordinary shares, set to run from May 2026 to May 2027, signalling a fresh phase in its capital management strategy.

ANZ Group Holdings Limited posted a 14% rise in cash profit for 1H26 to AUD 3.78 billion, driven by cost reductions and steady revenue, while declaring an 83-cent interim dividend with 75% franking.

Central Petroleum lifted March quarter sales revenue to $11.3 million, driven by higher gas volumes and prices, while securing a significant multi-year gas supply deal with the Northern Territory Government that supports a 40% production capacity increase at Palm Valley.

Whitehaven Coal’s March quarter production fell 14% due to seasonal wet weather in Queensland, but coal prices rose sharply and refinancing cut interest costs by up to A$55 million annually.

Pantoro Gold delivered 17,757 ounces of gold in Q3 2026, generated $88.4 million EBITDA, and approved a third underground mine, reinforcing its growth trajectory at Norseman.

Carnarvon Energy is gearing up for a high-impact Bedout Sub-basin drilling campaign in the first half of 2027, supported by a robust balance sheet and strategic investments.

Neuren Pharmaceuticals reported a solid A$30.4 million net profit in 2025, powered by a 15% rise in DAYBUE® royalties. The company is progressing its NNZ-2591 Phase 3 trial for Phelan-McDermid syndrome and has initiated a share buy-back amid perceived undervaluation.

Harmoney has reaffirmed its FY26 cash NPAT guidance of $13 million, propelled by robust loan origination growth, margin improvements, and operational efficiencies from its Stellare® 2.0 platform.

Northern Star Resources strengthened its cash flow and maintained FY26 production guidance above 1.5 million ounces despite cost inflation and operational challenges. The KCGM Mill Expansion remains on track for early FY27 commissioning, underpinning confidence reflected in a $500 million share buy-back announcement.

Australian Clinical Labs has been hit with a class action lawsuit linked to a 2022 cyberattack on Medlab Pathology, alleging breaches of consumer law and duty of care. The company denies the claims and plans a vigorous defence.

MA Credit Income Trust has approved an on-market buy-back of its units, adding a flexible tool to its capital management arsenal amid evolving market conditions.

Critical Metals Corp has consolidated its stake in the Tanbreez Rare Earths Project, gaining government approval to increase ownership to 92.5%, while European Lithium retains a 7.5% interest. This clearance removes a key hurdle, enabling the project’s development to accelerate.